Our Services
Medical Information
Helpful Resources
Published on: 6/15/2026
Diminished ovarian reserve (DOR) is a condition where the ovaries contain fewer eggs than expected for a woman's age. Fertility specialists diagnose DOR using two key tests: anti-Müllerian hormone (AMH) blood testing and antral follicle count (AFC) via transvaginal ultrasound. These results help predict how your ovaries may respond to fertility stimulation and guide personalized treatment options, such as IVF or egg donation.
Several factors influence ovarian reserve, including age, genetics, prior ovarian surgery, autoimmune conditions, smoking, and chemotherapy exposure. Egg quality—not just quantity—also plays a critical role in fertility outcomes.
If you're concerned about irregular cycles, difficulty conceiving, or family planning timelines, taking a few minutes now could save you months of uncertainty. A free, confidential symptom check can help you quickly identify whether your symptoms align with diminished ovarian reserve or other reproductive health conditions—giving you clear, personalized guidance on the right next steps to discuss with your doctor. Early insight matters, because fertility is time-sensitive.
Reviewed for medical accuracy: 06/15/2026
Diminished ovarian reserve (DOR) refers to a lower quantity and quality of eggs in the ovaries than expected for a woman's age. It does not always mean you cannot conceive, but it does influence fertility treatment options and timing. Two key tests fertility specialists use to assess ovarian reserve are the Anti-Müllerian Hormone (AMH) blood test and the Antral Follicle Count (AFC) via ultrasound. Understanding what these tests measure—and their limitations—can help you make informed decisions and discuss next steps confidently with your doctor.
AMH is a hormone produced by the granulosa cells of early-stage (pre-antral and small antral) follicles in the ovary. It reflects the size of the pool of small follicles—and indirectly, the quantity of eggs—remaining in the ovaries.
• How the AMH test works
• Interpreting AMH levels
• Limitations of the AMH test
Antral follicles are small, fluid-filled sacs in the ovaries that contain immature eggs. A transvaginal ultrasound examines each ovary to count the visible antral follicles (usually those measuring 2–10 mm in diameter).
• How the AFC test works
• Interpreting AFC results
• Limitations of AFC
Neither AMH nor AFC alone gives a complete picture. Together, they offer complementary insights:
• Assessing response to fertility treatment
• Personalizing your treatment plan
• Predicting time to menopause (with caution)
While AMH and AFC focus on egg quantity, these aspects also play a role:
• Age
• Lifestyle
• Medical history
• Genetic factors
Learning you have DOR can feel overwhelming, but there are proactive steps:
• Seek fertility counseling early
• Explore fertility preservation
• Review ovarian stimulation options
• Consider donor eggs or embryos
• Pay attention to signs of Primary Ovarian Insufficiency
Facing diminished ovarian reserve can be emotionally taxing. Here are ways to cope:
• Seek support
• Set realistic timelines
• Stay informed but balanced
While diminished ovarian reserve itself is not life-threatening, some related conditions merit prompt medical attention:
• Sudden pelvic pain or heavy bleeding
• Signs of ovarian hyperstimulation (severe abdominal pain, shortness of breath) during fertility treatment
• Symptoms of POI such as hot flashes, irregular periods, or night sweats in your 20s or 30s
If you experience any of these, contact your healthcare provider right away or visit the nearest emergency department.
Diminished ovarian reserve is a common finding that influences—but does not end—your fertility journey. AMH and AFC tests provide valuable data on your egg quantity, helping fertility specialists shape a personalized plan. Remember:
For personalized guidance, speak with your doctor or a reproductive endocrinologist about your AMH, AFC, and next steps. Always seek medical advice for anything that could be serious or life-threatening.
(References)
* Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020 Sep;114(3):477-484. doi: 10.1016/j.fertnstert.2020.06.012. Epub 2020 Jul 22. PMID: 32709282.
* Siristatidis C, Koliopoulos G, Dafopoulos K, Loutradis D. New insights into the diagnosis and management of diminished ovarian reserve. J Assist Reprod Genet. 2023 Dec;40(12):2709-2723. doi: 10.1007/s10815-023-02949-0. Epub 2023 Sep 25. PMID: 37747209.
* Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Semin Reprod Med. 2017 Jul;35(4):307-313. doi: 10.1055/s-0037-1604291. Epub 2017 Aug 16. PMID: 28817757.
* Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014 Nov-Dec;20(6):837-58. doi: 10.1093/humupd/dmu036. Epub 2014 Jul 25. PMID: 25062973.
* Broer SL, Dólleman M, van Disseldorp J, et al. Prediction of outcome in IVF using anti-Mullerian hormone (AMH): a systematic review and meta-analysis. Fertil Steril. 2014 Sep;102(3):723-730.e10. doi: 10.1016/j.fertnstert.2014.06.023. Epub 2014 Jul 22. PMID: 25060855.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.